De Luca Leonardo, Grippo Francesco, D'Errigo Paola, Burgio Alessandra, Rosato Stefano, Giordani Barbara, Duranti Giorgia, Baglio Giovanni
Department of Cardio-Thoracic and Vascular Medicine and Surgery, S.C. Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
ISTAT-Istituto Nazionale di Statistica, Rome, Italy.
Front Cardiovasc Med. 2025 Jun 6;12:1540783. doi: 10.3389/fcvm.2025.1540783. eCollection 2025.
To carry out a nationwide evaluation of both in- and out-of-hospital mortality for acute myocardial infarction (AMI) during the COVID-19 pandemic period in Italy.
This was a retrospective cohort study analysing overall mortality for AMI in Italy during the COVID-19 pandemic (March 1st, 2020-December 31st, 2021) and the previous 5 years (January 1st, 2015-February 29th, 2020). To carefully analyze both in- and out-of-hospital mortality for AMI (with or without concomitant COVID-19 infection) we used different institutional administrative sources of national data. Excess mortality related to AMI during the COVID-19 pandemic has been analyzed using the observed/expected ratio (OER).
Over the 5 years pre-pandemic period, 150,299 fatal events related to AMI occurred. During the pandemic, the number of deaths related to AMI was 28,673 in 2020 and declined to 26,688 in 2021. The overall OER was 1.18 [95% confidence intervals (CI): 1.15-1.22] in 2020 and 1.19 (95% CI: 1.15-1.22) while out-of-hospital OER was 1.24 (95% CI: 1.20-1.29) in 2020 and 1.21 (95% CI: 1.16-1.25) during the pandemic. When excluding COVID-19 related deaths, the number of observed in-hospital deaths did not significantly differ from the expected both in 2020 and 2021 while the excess remains unchanged for out-of-hospital mortality.
In this analysis of nationwide institutional administrative databases, we documented an increase in observed mortality compared to the expected during the COVID-19 pandemic in Italy. This mortality increase is mainly attributable to out-of-hospital fatal events and related to concomitant COVID-19 infection for hospitalized AMI patients.
对意大利新冠疫情期间急性心肌梗死(AMI)的院内和院外死亡率进行全国性评估。
这是一项回顾性队列研究,分析了意大利在新冠疫情期间(2020年3月1日至2021年12月31日)以及此前5年(2015年1月1日至2020年2月29日)的AMI总体死亡率。为了仔细分析AMI的院内和院外死亡率(无论是否伴有新冠病毒感染),我们使用了不同的国家数据机构行政来源。使用观察/预期比值(OER)分析了新冠疫情期间与AMI相关的超额死亡率。
在疫情前的5年里,发生了150299例与AMI相关的死亡事件。在疫情期间,2020年与AMI相关的死亡人数为28673例,2021年降至26688例。2020年总体OER为1.18[95%置信区间(CI):1.15 - 1.22],2021年为1.19(95%CI:1.15 - 1.22),而疫情期间2020年院外OER为1.24(95%CI:1.20 - 1.29),2021年为1.21(95%CI:1.16 - 1.25)。排除与新冠病毒相关的死亡后,2020年和2021年观察到的院内死亡人数与预期相比无显著差异,而院外死亡率的超额部分保持不变。
在这项对全国机构行政数据库的分析中,我们记录了意大利在新冠疫情期间观察到的死亡率相较于预期有所增加。这种死亡率的增加主要归因于院外死亡事件,且与住院AMI患者同时感染新冠病毒有关。